Labbé, Vincent
Ederhy, Stephane
Lapidus, Nathanael
Salem, Joe-Elie
Trinh-Duc, Antoine
Cohen, Ariel
Fartoukh, Muriel
Voiriot, Guillaume
Article History
Received: 21 July 2020
Accepted: 21 November 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: AC received a research grant from Resicard; and consultant/advisory board fees from Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Novartis, and Pfizer, unrelated with the present study. GV received research grant from BioMérieux, SOS Oxygène, Janssen unrelated to the present study; and advisory board fees from BioMérieux unrelated to the present study. VL receives advisory board fees from Amomed unrelated with the present study. AT, JS, MF, NL, and SE declared no relevant conflict of interest.
: The study has been approved by the local institutional ethical board (Sorbonne University, CER-2020-14) as a component of standard care and patient consent was waived, as per French Law.
: Written and oral information was given to the patient or next of kin.
Free to read: This content has been made available to all.